This is a single cohort observational safety study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study. Data will be collected from centre's medical records for up to 5 years or death.
Study Type
OBSERVATIONAL
Enrollment
3,942
There is no planned investigational product or a treatment regimen prescribed by this protocol. Decision about a treatment regimen will be made according to the local practice and in the best interest of individual patients.
Incidence of symptomatic congestive heart failure\n(CHF) using New York Heart Association class II, III and IV, and cardiac death
Time frame: On treatment and up to 5 years follow-up
Time to onset and the time to recovery of symptomatic congestive heart failure
Time frame: On treatment and up to 5 years follow-up
Incidence of asymptomatic cardiac failure and other significant cardiac conditions
Time frame: On treatment and up to 5 years follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie
Graz, Austria
LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie
Graz, Austria
Lhk Klagenfurt; Abt. Für Gynäkologie
Klagenfurt, Austria
LKH Hochsteiermark; Abt. für Innere Medizin
Leoben, Austria
Ordensklinikum Linz Barmherzige Schwestern; Abt. fur Innere Medizin 1
Linz, Austria
Lhk Feldkirch; Interne Medizin Abt.
Rankweil, Austria
Lkh Salzburg - Univ. Klinikum Salzburg; Iii. Medizinische Abt.
Salzburg, Austria
A. Ö. Krankenhaus Der Barmherzigen Brüder; Abt. Für Chirurgie
Sankt Veit an der Glan, Austria
A.Ö. Lhk; Ii. Medizinische Abt. Mit Schwerpunkt Gaströnter. & Onkologie
Steyr, Austria
Krankenanstalt Rudolfstiftung; I. Med. Abt.
Vienna, Austria
...and 195 more locations